Success Stories: NIW Approval Expedited for a Vietnamese Lecturer in Biotechnologies, Thanks to Premium Processing Upgrade and Our Teamwork

Posted by wegreened on May 8, 2023 in NIW, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“Thank you for your wonderful service during this time. Thanks to your consultant, my I-140 has been approved already. I don't know how to show my happiness now, just know it's wonderful and amazing.”

On February 22^nd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Lecturer in the Field of Biotechnologies (Approval Notice).

General Field: Biotechnologies

Position at the Time of Case Filing: Lecturer

Country of Origin: Vietnam

Country of Residence at the Time of Filing: Vietnam

Approval Notice Date: February 22^nd, 2023

Processing Time: 2 months, 3 days

Case Summary:

An NIW (National Interest Waiver) application requires the petitioner to prove their worth to the country via evidence of nationally-significant research and awards of recognition from institutions and individuals. So when we got a request from an expert in the field of biotechnologies to file her NIW petition, we made sure to prove beyond a reasonable doubt her worth to the nation. We did this by using the following data:

Her proposed endeavor is to continue her research on investigating quality control techniques, in vitro diagnostic tests, and antiviral/antibacterial drugs to develop novel approaches for combating emerging infectious diseases.
Her research advancing her proposed endeavor is of great importance because it has contributed to understanding how to minimize the spread of SARS-CoV-2, thereby limiting the combined burden of COVID-19 and “long COVID.”
Her proposed endeavor also has broad implications for the United States since as of November 8, 2022, the United States has performed 1,132,648,806 COVID-19 tests, the highest number of countries worldwide.
Her work in developing and advancing PCR protocols throughout the COVID-19 pandemic thus offered fundamental advances to support this burgeoning and lucrative industry, providing data fundamental to ensure continued success and progress in studying biotechnologies. Her work is therefore vital for the economic health of America in addition to the physical health of its people.
Academically, her research has resulted in 14 peer-reviewed journal articles (5 of them first-authored) and 2 preprint articles which have been cited a total of 34 times according to Google Scholar.
Not only this but her work found support from 3 recommenders who wrote letters supporting the continuation of her work in the U.S. One of them wrote:

“Considering the influence that her work has had on the field, alongside the inherent merits of her work, which improves testing procedures for infectious diseases, it is clear that [the client] must be permitted to conduct her research in the United States without impediment.”

Additionally, we found that she has pursued research directly related to her proposed endeavor of investigating quality control techniques, in vitro diagnostic tests, and antiviral/antibacterial drugs for 4 years. This has given her the required expertise to continue her research here in the U.S.

When these factors were put together by our team in her petition, it made for a strong case in her favor. We are glad that we could be of assistance to her in this process and we wish her success in her future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%